What nobody tells you when you go the other way.
The same grant instincts that help you win SBIRs can quietly hurt you in academic funding. Here's why.
Most of the conversation about academic versus biotech grants runs in one direction: researchers moving into the startup world and learning that the rules changed.
But there's another version of this transition that doesn't get talked about as much, and it's worth a moment.
What happens when a biotech founder, someone who learned grants in the startup world, needs to navigate academic-style funding for the first time?
It happens more than you'd think. Collaborative grants, foundation funding, certain NIH mechanisms that don't follow the SBIR structure come up for startup founders, especially as companies mature and partnerships with academic institutions deepen.
And the adjustment, it turns out, goes both ways.
Founders who learned grant writing through SBIR are often extremely good at the commercial narrative. They know how to write a crisp significance section that makes the market case, how to frame preliminary data around real-world viability, how to build a team section that signals operational credibility.
What they sometimes struggle with is the pure scientific rigor that academic reviewers expect as baseline. The depth of literature engagement. The methodological detail. The careful, defensible framing of a hypothesis that makes no promises it can't keep. The instinct to front-load the commercial story can actually work against you when the reviewer panel is entirely academic and is primarily asking whether this is good science.
The underlying lesson is the same in both directions: know your audience before you write a word. Academic reviewers and SBIR reviewers are both smart, both skeptical, and both reading a lot of applications. But they are asking different questions, and the application that answers the wrong questions confidently and clearly will still score below the one that answers the right ones.
Write like a scientist. Think like a founder. Know which mode the room is in before you start.
Not sure how to position your application for the reviewers you're writing for?
Whether you're a biotech founder navigating academic-style funding for the first time or a researcher moving into the commercial side of grants, the right approach depends on knowing what your reviewers are actually looking for. Let's figure out how to position your project so you're answering the questions that matter to the people evaluating it.
Comments